{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:18:19Z","timestamp":1792444699443,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012232","name":"National Key Clinical Specialty Discipline Construction Program of China","doi-asserted-by":"publisher","award":["FYZC2024-095"],"award-info":[{"award-number":["FYZC2024-095"]}],"id":[{"id":"10.13039\/501100012232","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"DOI":"10.1186\/s13052-025-02137-x","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:04:30Z","timestamp":1761120270000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese children: a retrospective study of clinical features and prognosis"],"prefix":"10.1186","volume":"51","author":[{"given":"Yu","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guitao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchen","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"issue":"10","key":"2137_CR1","doi-asserted-by":"publisher","first-page":"001910","DOI":"10.1099\/jmm.0.001910","volume":"73","author":"RS Rowlands","year":"2024","unstructured":"Rowlands RS, Meyer Sauteur PM, Beeton ML, Esgmac OBOTESGFMACI. Mycoplasma pneumoniae: not a typical respiratory pathogen. J Med Microbiol. 2024;73(10):001910. https:\/\/doi.org\/10.1099\/jmm.0.001910.","journal-title":"J Med Microbiol"},{"issue":"10","key":"2137_CR2","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1002\/ppul.27110","volume":"59","author":"G Ding","year":"2024","unstructured":"Ding G, Yang L, Xu C, Vinturache A, Zhang Y. Necrotizing pneumonia associated with macrolide-resistant Mycoplasma in a child. Pediatr Pulmonol. 2024;59(10):2679\u201380. https:\/\/doi.org\/10.1002\/ppul.27110.","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"2137_CR3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/INF.0000000000004568","volume":"44","author":"E Bolormaa","year":"2025","unstructured":"Bolormaa E, Park JY, Choe YJ, Kang CR, Choe SA, Mylonakis E. Treatment of Macrolide-resistant Mycoplasma pneumoniae pneumonia in children: A Meta-analysis of macrolides versus tetracyclines. Pediatr Infect Dis J. 2025;44(3):200\u20136. https:\/\/doi.org\/10.1097\/INF.0000000000004568.","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"2137_CR4","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s12519-024-00831-0","volume":"20","author":"YS Wang","year":"2024","unstructured":"Wang YS, Zhou YL, Bai GN, Li SX, Xu D, Chen LN, et al. Expert consensus on the diagnosis and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. World J Pediatr. 2024;20(9):901\u201314. https:\/\/doi.org\/10.1007\/s12519-024-00831-0.","journal-title":"World J Pediatr"},{"key":"2137_CR5","doi-asserted-by":"publisher","unstructured":"Branch of Pediatric Critical Care Physicians CMA, Association BCM, Center GPMCHHPCHPCMR, Center for Evidence-Based Medicine SoBM., Lanzhou University\/WHO Guidelines for Practice and Knowledge Transformation Cooperation Center\/Gansu Province Medical Guideline Technology Center (Feng Z-C Ezc, Yi B Ew0c, [Clinical practice guidelines for bronchoalveolar lavage in Chinese children (2024)]. Zhongguo Dang Dai Er Ke Za Zhi. 2024;26(1):1\u201313. https:\/\/doi.org\/10.7499\/j.issn.1008-8830.2308072","DOI":"10.7499\/j.issn.1008-8830.2308072"},{"key":"2137_CR6","doi-asserted-by":"publisher","first-page":"1181633","DOI":"10.3389\/fcimb.2023.1181633","volume":"13","author":"J Li","year":"2023","unstructured":"Li J, Liu L, Zhang H, Guo J, Wei X, Xue M, et al. Severe problem of macrolides resistance to common pathogens in China. Front Cell Infect Microbiol. 2023;13:1181633. https:\/\/doi.org\/10.3389\/fcimb.2023.1181633.","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"2137_CR7","doi-asserted-by":"publisher","first-page":"e2220949","DOI":"10.1001\/jamanetworkopen.2022.20949","volume":"5","author":"K Kim","year":"2022","unstructured":"Kim K, Jung S, Kim M, Park S, Yang HJ, Lee E. Global trends in the proportion of Macrolide-Resistant Mycoplasma pneumoniae infections: A systematic review and Meta-analysis. JAMA Netw Open. 2022;5(7):e2220949. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.20949.","journal-title":"JAMA Netw Open"},{"issue":"9","key":"2137_CR8","doi-asserted-by":"publisher","first-page":"832","DOI":"10.3760\/cma.j.issn.0253-9624.2017.09.011","volume":"51","author":"WX Shi","year":"2017","unstructured":"Shi WX, Wu SS, Gong C, Li AH, Huang F. [The epidemiological characteristics and drug resistance of Mycoplasma pneumoniae in patients with community-acquired pneumonia during 2011\u20132015 in 5 Sentinel hospitals in Beijing]. Zhonghua Yu Fang Yi Xue Za Zhi. 2017;51(9):832\u20136. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-9624.2017.09.011.","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"issue":"7","key":"2137_CR9","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3760\/cma.j.cn112150-20231123-00368","volume":"58","author":"BB Mao","year":"2024","unstructured":"Mao BB, Chen DN, Lu WW, Liu CY, Li ZL, Chen CS, et al. [Epidemic characteristics of Mycoplasma pneumoniae infection and drug-resistant gene mutations in hospitalized children aged 0\u201317 in Ningbo City from 2019 to 2023]. Zhonghua Yu Fang Yi Xue Za Zhi. 2024;58(7):1035\u201340. https:\/\/doi.org\/10.3760\/cma.j.cn112150-20231123-00368.","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"issue":"1","key":"2137_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/14787210.2018.1414599","volume":"16","author":"H Lee","year":"2018","unstructured":"Lee H, Yun KW, Lee HJ, Choi EH. Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Expert Rev Anti Infect Ther. 2018;16(1):23\u201334. https:\/\/doi.org\/10.1080\/14787210.2018.1414599.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"2137_CR11","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1186\/s12879-024-09612-6","volume":"24","author":"M He","year":"2024","unstructured":"He M, Xie J, Rui P, Li X, Lai M, Xue H, et al. Clinical efficacy of macrolide antibiotics in Mycoplasma pneumoniae pneumonia carrying a macrolide-resistant mutation in the 23 S rRNA gene in pediatric patients. BMC Infect Dis. 2024;24(1):758. https:\/\/doi.org\/10.1186\/s12879-024-09612-6.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"2137_CR12","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3390\/jcm11020306","volume":"11","author":"YJ Choi","year":"2022","unstructured":"Choi YJ, Chung EH, Lee E, Kim CH, Lee YJ, Kim HB, et al. Clinical characteristics of Macrolide-Refractory Mycoplasma pneumoniae pneumonia in Korean children: A multicenter retrospective study. J Clin Med. 2022;11(2):306. https:\/\/doi.org\/10.3390\/jcm11020306.","journal-title":"J Clin Med"},{"issue":"6","key":"2137_CR13","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.3201\/eid2706.203206","volume":"27","author":"MM Lanata","year":"2021","unstructured":"Lanata MM, Wang H, Everhart K, Moore-Clingenpeel M, Ramilo O, Leber A. Macrolide-Resistant Mycoplasma pneumoniae infections in Children, Ohio, USA. Emerg Infect Dis. 2021;27(6):1588\u201397. https:\/\/doi.org\/10.3201\/eid2706.203206.","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"2137_CR14","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.3201\/eid2607.200017","volume":"26","author":"YC Chen","year":"2020","unstructured":"Chen YC, Hsu WY, Chang TH. Macrolide-Resistant Mycoplasma pneumoniae infections in pediatric Community-Acquired pneumonia. Emerg Infect Dis. 2020;26(7):1382\u201391. https:\/\/doi.org\/10.3201\/eid2607.200017.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"2137_CR15","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jmii.2018.09.009","volume":"52","author":"TI Yang","year":"2019","unstructured":"Yang TI, Chang TH, Lu CY, Chen JM, Lee PI, Huang LM, et al. Mycoplasma pneumoniae in pediatric patients: do macrolide-resistance and\/or delayed treatment matter. J Microbiol Immunol Infect. 2019;52(2):329\u201335. https:\/\/doi.org\/10.1016\/j.jmii.2018.09.009.","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"2137_CR16","doi-asserted-by":"publisher","first-page":"2386636","DOI":"10.1080\/07853890.2024.2386636","volume":"56","author":"L Gao","year":"2024","unstructured":"Gao L, Sun Y. Laboratory diagnosis and treatment of Mycoplasma pneumoniae infection in children: a review. Ann Med. 2024;56(1):2386636. https:\/\/doi.org\/10.1080\/07853890.2024.2386636.","journal-title":"Ann Med"},{"issue":"1","key":"2137_CR17","doi-asserted-by":"publisher","first-page":"5632","DOI":"10.1038\/s41598-024-55311-2","volume":"14","author":"P Li","year":"2024","unstructured":"Li P, Wang W, Zhang X, Pan J, Gong L. Observational retrospective clinical study on clinical features of macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese pediatric cases. Sci Rep. 2024;14(1):5632. https:\/\/doi.org\/10.1038\/s41598-024-55311-2.","journal-title":"Sci Rep"},{"key":"2137_CR18","doi-asserted-by":"publisher","first-page":"1115009","DOI":"10.3389\/fped.2023.1115009","volume":"11","author":"M Leng","year":"2023","unstructured":"Leng M, Yang J, Zhou J. The molecular characteristics, diagnosis, and treatment of macrolide-resistant Mycoplasma pneumoniae in children. Front Pediatr. 2023;11:1115009. https:\/\/doi.org\/10.3389\/fped.2023.1115009.","journal-title":"Front Pediatr"},{"key":"2137_CR19","doi-asserted-by":"publisher","first-page":"7339","DOI":"10.2147\/JIR.S491981","volume":"17","author":"M Leng","year":"2024","unstructured":"Leng M, Xu L, Dong Z, Yang J. The clinical significance of pathogen loads and macrolide resistance levels for macrolide-Resistant Mycoplasma pneumoniae pneumonia in children. J Inflamm Res. 2024;17:7339\u201346. https:\/\/doi.org\/10.2147\/JIR.S491981.","journal-title":"J Inflamm Res"},{"issue":"11","key":"2137_CR20","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.7499\/j.issn.1008-8830.2407129","volume":"26","author":"W Zhang","year":"2024","unstructured":"Zhang W, Wang Y, Cai LJ. [Analysis of multidrug resistance gene locus mutations and clinical significance in children with Mycoplasma pneumoniae pneumonia]. Zhongguo Dang Dai Er Ke Za Zhi. 2024;26(11):1176\u201381. https:\/\/doi.org\/10.7499\/j.issn.1008-8830.2407129.","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"issue":"1","key":"2137_CR21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13052-022-01376-6","volume":"48","author":"XW Zhan","year":"2022","unstructured":"Zhan XW, Deng LP, Wang ZY, Zhang J, Wang MZ, Li SJ. Correlation between Mycoplasma pneumoniae drug resistance and clinical characteristics in Bronchoalveolar lavage fluid of children with refractory Mycoplasma pneumoniae pneumonia. Ital J Pediatr. 2022;48(1):190. https:\/\/doi.org\/10.1186\/s13052-022-01376-6.","journal-title":"Ital J Pediatr"},{"issue":"1","key":"2137_CR22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13052-025-01932-w","volume":"51","author":"W Xu","year":"2025","unstructured":"Xu W, Wang H, Wen X, Yang H, Zhao S, Liu J. Risk factors for bronchiolitis obliterans development in children after Mycoplasma pneumoniae pneumonia: a retrospective study of 981 patients. Ital J Pediatr. 2025;51(1):105. https:\/\/doi.org\/10.1186\/s13052-025-01932-w.","journal-title":"Ital J Pediatr"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-02137-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-025-02137-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-02137-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:04:34Z","timestamp":1761120274000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-025-02137-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2137"],"URL":"https:\/\/doi.org\/10.1186\/s13052-025-02137-x","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The performed study\u2019s protocol was following the principles of the declaration of Helsinki and approved by the Ethical Committee of Fu Yang People\u2019s Hospital (2024\u2009\u2212\u2009240). The informed consent was waived by the Ethical Committee of Fu Yang People\u2019s Hospital due to retrospective nature of study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"289"}}